Verastem, Inc.

NasdaqCM:VSTM

Sector

🏥 Health Care

Industries

🔬 Clinical Trials

🧬 Biotechnology

Location

United States

Market Cap

USD 342.33 M

Share Price

USD 6.23

Avg Daily Volume

2,164,791

Change (1 day)

-0.95%

Change (1 year)

133.33%

Change (YTD)

20.50%

Verastem, Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD -115.15 M

Verastem, Inc. Free Cash Flow is USD -115.15 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 21.86% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Verastem, Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -94.50 M, a 46.10% change year over year.
Verastem, Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -64.68 M, a 20.97% change year over year.
Verastem, Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -53.47 M, a -12,034.15% change year over year.
Verastem, Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 448.00 K, a -100.33% change year over year.